Higher adherence to the 2017 French dietary guidelines is linked to lower mortality risk, particularly for cardiovascular and some cancer deaths, though lung cancer risk trends reversed at high adherence levels.
Targeting Novartis’ Scemblix, Enliven lays out case for leukemia drug in early results
Enliven Therapeutics released new Phase 1 data for its chronic myeloid leukemia program (CML) it hopes can eventually compete with Novartis’ Scemblix. The experimental therapy